CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 
Home » Lung Cancer

 

Exploring the Best Options for Maintenance Therapy in NSCLC

February 22, 2013

Current chemotherapy for advanced non-small-cell lung cancer (NSCLC) is as good as it can get so, according to one Italian oncologist, so clinicians need to turn their attention to choosing the ideal maintenance regimen for patients who respond well to first-line treatment. A review article culls the latest data on NSCLC maintenance therapy, exploring the pros and cons of several approaches to prolonging survival without upping toxicity.

RESULT: Maintenance therapy: a new treatment paradigm in advanced non-small-cell lung cancer
Current Opinion in Oncology | Mar 01, 2013 (FREE FULL TEXT)


Maintenance therapy with gefitinib(Drug information on gefitinib) (Iressa) boosted progression-free survival (PFS) compared with placebo in an Asia-based study of advanced NSCLC patients who achieved disease control after initial chemotherapy. But is PFS a solid enough outcome on which to base the benefits of maintenance therapy? The trialists say “yes,” but an expert commentary on the study offers some perspective on relying on PFS for making long-term treatment protocol decisions.

RESULT: Is benefit of maintenance therapy for NSCLC best defined by progression-free survival?
The Lancet Oncology | May 01, 2012 (FREE FULL TEXT with registration)

RESULT: Gefitinib versus placebo as maintenance therapy in patients with locally advanced or metastatic non-small-cell lung cancer (INFORM; C-TONG 0804): a multicentre, double-blind randomised phase 3 trial
The Lancet Oncology | May 01, 2012 (Free abstract. Full text $31.50)


URL

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.

More on this topic

Erlotinib Plus WBRT Effective for NSCLC Brain Metastases

In Second-Line Treatment of Advanced NSCLC, Adding Carboplatin to Pemetrexed Yields No Benefit

Gemcitabine and Erlotinib Both Effective Maintenance Therapies in NSCLC

ALK Mutation Yields Poorer Survival in NSCLC Patients in Pre–ALK-Inhibitor Era

Sorafenib Added to Chemo Fails to Improve Survival in NSCLC

Exploring the Best Options for Maintenance Therapy in NSCLC

Helping Lung Cancer Patients Survive Treatment-Related Cachexia






 
RELATED CONTENT

ASCO: Dabrafenib Shows Activity in BRAF-Mutated NSCLC Patients
June 18, 2013
ASCO: Sunitinib Improves PFS in Small-Cell Lung Cancer
June 12, 2013
ASCO: Treating Lung Cancer After Targeted Therapy–Resistance
June 11, 2013
ASCO: Heat Shock Protein 90 Inhibitor Shows Promise in NSCLC
June 6, 2013
ASCO: Proteomic Stratification Test Can Help Guide Second-Line Treatment of NSCLC
June 6, 2013
 
CANCER MANAGEMENT

Non–Small-Cell Lung Cancer
   • Screening and prevention
   • Signs and symptoms
   • Staging and prognosis
   • Treatment
Small-Cell Lung Cancer
Mesothelioma
Thymoma
 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
   SEARCH MEDICA RX
   Browse drugs by name:
A B C D E F G H I J
K L M N O P Q R S T
U V W X Y Z All      
   Search for drugs:
Search

 

 
FROM PHYSICIANS PRACTICE
Key Differences between FQHCs and RHCs
Chastity Werner, RHIT, June 13, 2013
FQHCs and RHCs take up a unique niche among physician practices. And that affects compensation and billing.
Improving Care Coordination in Your Practice
Susanne Madden,  June 12, 2013
Practices are feverishly working to control the rising costs of healthcare - effective care coordination can help.
Refunding Overpayments: Two Options for Medical Practices
Ericka L. Adler,  June 12, 2013
Medicare and Medicaid providers must return overpayments once identified. Here are two different refund approaches for practices to consider when necessary.
Four Easy Ways to Boost Patient Time of Service Collections
Aubrey Westgate,  June 12, 2013
Simple ways your medical practice staff can increase the likelihood patients will pay when presenting for appointments.
iPad Alternatives for Mobile Physicians
Marisa Torrieri, June 11, 2013
As more physicians are seeing the merits of media tablets, the market is expanding, too.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Papillary Thyroid Carcinoma
  • Robotic-Assisted Radical Prostatectomy: Who Is Benefiting?
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • A 48-Year-Old Woman With Irregular Vaginal Bleeding
  • Cannabis Linked to Decreased Bladder Cancer Risk
  • Breast Cancer Screening, Risk, and Options for High-Risk Women
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Rising PSA Level in a 46-Year-Old Man
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • ASCO: Dabrafenib Shows Activity in BRAF-Mutated NSCLC Patients
  • Preventing Burnout in Oncology
  • ASCO: Yoga Reduces Insomnia in Breast Cancer Patients Treated With Hormone Therapy
  • Physical Activity Across the Cancer Continuum
  • Exercise After Cancer Diagnosis: Time to Get Moving
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • Preventing Exposure to Hazardous Drugs
  • ASCO: Vinegar Screening Significantly Reduces Cervical Cancer Mortality
  • ASCO: Sulforaphane in Prostate Cancer Found Worthy of Further Investigation
  • Study: Recurrent Heartburn Ups Risk for Throat Cancer
  • Radiation-Induced Enteritis: Incidence, Mechanisms, and Management
  • HER2-Directed Therapy for Metastatic Breast Cancer
  • Accelerated Partial-Breast Irradiation: The Current State of Our Knowledge
  • It’s Time for Clinicians to Reconsider Their Proscription Against the Use of Soyfoods by Breast Cancer Patients
  • 50 Shades of Pink—And Why It Helps to Know the Difference
Click here to subscribe to our newsletter

 
SearchMedica Search Result

Find peer-reviewed literature and websites for practicing medical professionals

CME on Lung Cancer
Evidence on Lung Cancer
Guidelines on Lung Cancer
Patient Education on Lung Cancer
Clinical Trials on Lung Cancer
Practical Articles on Lung Cancer
Research and Reviews on Lung Cancer
All "Lung Cancer" results

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy